Specifically, patients with metastasizing tumors have high levels of ST6Gal I in their serum, and serum levels of ST6Gal I are correlated with the progression of colorectal carcinomas and cancer metastasis [7-13]. The gene discussed is ST6GAL1; the disease is colorectal carcinoma.